Acton Pharma Gets FDA Nod for an Inhaled Steroid to Treat Asthma

Acton Pharmaceuticals said it has secured approval from the U.S. Food and Drug Administration of its supplemental New Drug Application for an inhaled steroid to treat asthma.
Healthcare Global